Glucagon-like peptide-1 is a hormone that naturally occurs in the ... significantly enhance the treatment experience and outcomes of using the Ozempic shot for weight loss. They are typically ...

Scientists have discovered a naturally occurring molecule that aids appetite control and weight loss so well, it may compete ...

Eli Lilly launched its weight loss drug Mounjaro in India. According to the company, the injection is supposed to be taken ...

This medication is a glucagon-like peptide-1 (GLP-1 ... Research has shown that semaglutide injections are effective for weight loss in people without diabetes. However, regardless of whether ...

Eli Lilly and Company (India) on Thursday said it has launched a first-of-its-kind medication for obesity and type 2 diabetes ...

FDA is aware that some patients and health care professionals may look to unapproved versions of GLP-1 – glucagon-like peptide-1 receptor agonists – drugs, including semaglutide and tirzepatide, as an ...

The new class of weight-loss medicines that has taken the world by a storm will now become available in India, with the ...

US pharmaceutical company Eli Lilly has launched Mounjaro, a diabetes and weight-loss drug, in India. Priced at Rs 3,500 for a 2.5 mg vial, the ‘game-changing’ medication has debuted in the Indian ...